Related Experiment Video
Updated: Mar 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for
Adeola Y Makinde1, Iris Eke1, Molykutty J Aryankalayil1
1Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Understanding radiation-inducible changes and multifraction (MF) adaptation offers new therapeutic targets. Targeting these adaptations in combined treatments can enhance precision medicine and immunotherapy outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- Technological advancements in radiation therapy and targeted inhibitors create new therapeutic opportunities.
- Mathematical models guide radiation regimens, but deeper molecular insights are needed.
- Tumor genetic complexity and adaptive responses to treatment necessitate innovative strategies.
Purpose of the Study:
- To explore the therapeutic potential of targeting radiation-inducible changes and multifraction (MF) adaptation.
- To identify new targets for combined modality treatments in precision medicine and immunotherapy.
- To integrate pretreatment molecular data with MF-adaptive responses for focused radiation therapy.
Main Methods:
- Reviewing mathematical models of radiation dose and fractionation.
- Analyzing molecular and cellular effects of individual radiation doses.
- Investigating multifraction (MF) adaptation to repeated radiation exposure.
Main Results:
- Radiation-inducible changes and MF adaptation present unique therapeutic targets.
- Potential targets include transcription factors, immune responses, and cell stemness.
- Combining molecular data with MF-adaptive responses can refine radiation therapy.
Conclusions:
- Targeting radiation-induced molecular and cellular adaptations can improve treatment efficacy.
- Multifraction adaptation offers novel strategies for combined radiochemotherapy and radioimmunotherapy.
- Integrating adaptive response data is crucial for advancing precision radiation oncology and immunotherapy.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...